Physician profile
Michael John Talone
NPI 1023006202
$13,968.46
in general payments reported to CMS, 2019-2025
18 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,027 · 2020: $4,364 · 2021: $332 · 2022: $484 · 2023: $2,377 · 2024: $141 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415 · Travel and Lodging: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.45 |
| Travel and Lodging | $1,346.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $9,860.49 | 2019-2024 | Myday Contact Lens, Clariti Contact Lens |
| Biotissue Holdings INC. | $1,681.90 | 2019-2024 | |
| Lombart Brothers, INC. | $500.00 | 2019 | |
| Topcon Healthcare, INC. | $458.46 | 2020-2025 | |
| Bausch & Lomb Americas INC. | $310.55 | 2022-2024 | Biotrue One Day, Infuse |
| Johnson & Johnson Vision Care, INC. | $178.80 | 2023-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $172.90 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $157.12 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $133.12 | 2019-2021 | |
| Alcon Vision LLC | $128.28 | 2019-2025 | Dailies Total1, Precision7, Precision 1 |
| Allergan, INC. | $92.77 | 2019-2021 | |
| Abbvie INC. | $65.17 | 2022-2023 | Alphagan P, Lumigan |
| Maculogix, INC. | $49.85 | 2020 | |
| Alcon Research LLC | $49.71 | 2019 | |
| Kala Pharmaceuticals, INC. | $49.35 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $46.69 | 2021 | |
| Dompe US, INC. | $17.07 | 2021 | |
| Shire North American Group INC | $16.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Talone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.